The European Medicines Agency approves two relevant vaccines for poultry farming

The Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) met from 16 to 18 April to address a series of issues. At that meeting, the CVMP adopted by consensus a positive opinion for a marketing authorization application for an effective vaccine against currently circulating strains of highly pathogenic avian influenza (HPAI). This is Innovax-ND-H5 (Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), which expresses the Newcastle disease virus fusion protein gene and the Newcastle disease virus hemagglutinin gene. avian influenza subtype H5, live), from Msd Animal Health, a new vaccine for the active immunization of day-old chicks or 18- to 19-day-old embryonated hen eggs to reduce mortality, clinical signs and virus shedding due to to infection by the HPAI virus type H5. Additionally, the committee adopted by consensus a positive opinion for Hipra Laboratories' marketing authorization application for RESPIVAC TRT (turkey rhinotracheitis ...